Antimicrobial resistance among GLASS pathogens in Morocco: an epidemiological scoping review.
Antimicrobial resistance
Bacteria
Global antimicrobial resistance surveillance system
Morocco
Scoping review
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
07 May 2022
07 May 2022
Historique:
received:
16
01
2022
accepted:
19
04
2022
entrez:
7
5
2022
pubmed:
8
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
Monitoring of antimicrobial resistance (AMR) is of great importance due to the frequency of strains becoming increasingly resistant to antibiotics. This review, using a public health focused approach, which aims to understand and describe the current status of AMR in Morocco in relation to WHO priority pathogens and treatment guidelines. PubMed, ScienceDirect and Google Scholar Databases and grey literature are searched published articles on antimicrobial drug resistance data for GLASS priority pathogens isolated from Morocco between January 2011 and December 2021. Articles are screened using strict inclusion/exclusion criteria. AMR data is extracted with medians and IQR of resistance rates. Forty-nine articles are included in the final analysis. The most reported bacterium is Escherichia coli with median resistance rates of 90.9%, 64.0%, and 56.0%, for amoxicillin, amoxicillin-clavulanic acid, and co-trimoxazole, respectively. Colistin had the lowest median resistance with 0.1%. A median resistance of 63.0% is calculated for amoxicillin-clavulanic acid in Klebsiella pneumonia. Imipenem resistance with a median of 74.5% is reported for Acinetobacter baumannii. AMR data for Streptococcus pneumonie does not exceed 50.0% as a median. Whilst resistance rates are high for most of GLASS pathogens, there are deficient data to draw vigorous conclusions about the current status AMR in Morocco. The recently join to the GLASS system surveillance will begin to address this data gap.
Sections du résumé
BACKGROUND
BACKGROUND
Monitoring of antimicrobial resistance (AMR) is of great importance due to the frequency of strains becoming increasingly resistant to antibiotics. This review, using a public health focused approach, which aims to understand and describe the current status of AMR in Morocco in relation to WHO priority pathogens and treatment guidelines.
METHODS
METHODS
PubMed, ScienceDirect and Google Scholar Databases and grey literature are searched published articles on antimicrobial drug resistance data for GLASS priority pathogens isolated from Morocco between January 2011 and December 2021. Articles are screened using strict inclusion/exclusion criteria. AMR data is extracted with medians and IQR of resistance rates.
RESULTS
RESULTS
Forty-nine articles are included in the final analysis. The most reported bacterium is Escherichia coli with median resistance rates of 90.9%, 64.0%, and 56.0%, for amoxicillin, amoxicillin-clavulanic acid, and co-trimoxazole, respectively. Colistin had the lowest median resistance with 0.1%. A median resistance of 63.0% is calculated for amoxicillin-clavulanic acid in Klebsiella pneumonia. Imipenem resistance with a median of 74.5% is reported for Acinetobacter baumannii. AMR data for Streptococcus pneumonie does not exceed 50.0% as a median.
CONCLUSIONS
CONCLUSIONS
Whilst resistance rates are high for most of GLASS pathogens, there are deficient data to draw vigorous conclusions about the current status AMR in Morocco. The recently join to the GLASS system surveillance will begin to address this data gap.
Identifiants
pubmed: 35525923
doi: 10.1186/s12879-022-07412-4
pii: 10.1186/s12879-022-07412-4
pmc: PMC9077917
doi:
Substances chimiques
Anti-Bacterial Agents
0
Amoxicillin-Potassium Clavulanate Combination
74469-00-4
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
438Informations de copyright
© 2022. The Author(s).
Références
Clin Microbiol Rev. 2018 Feb 14;31(2):
pubmed: 29444952
Med Mal Infect. 2016 May;46(3):157-62
pubmed: 26897308
J Glob Antimicrob Resist. 2018 Sep;14:297-301
pubmed: 29842977
Nat Commun. 2014 Dec 17;5:5792
pubmed: 25517437
Arch Pediatr. 2011 Dec;18(12):1265-70
pubmed: 21978670
Prog Urol. 2014 Jun;24(7):451-5
pubmed: 24861685
J Glob Antimicrob Resist. 2017 Mar;8:90-96
pubmed: 28039104
Ann Fr Anesth Reanim. 2013 Jan;32(1):60-2
pubmed: 23199846
Microb Drug Resist. 2012 Apr;18(2):157-60
pubmed: 22217142
Expert Opin Pharmacother. 2008 Jan;9(1):23-37
pubmed: 18076336
Int J Antimicrob Agents. 2020 Jan;55(1):105833
pubmed: 31730892
Lancet Infect Dis. 2018 Dec;18(12):e379-e394
pubmed: 30292478
Crit Rev Food Sci Nutr. 2017 Sep 2;57(13):2857-2876
pubmed: 26464037
Braz J Infect Dis. 2012 May-Jun;16(3):279-83
pubmed: 22729197
Microorganisms. 2020 Jun 04;8(6):
pubmed: 32512756
Pan Afr Med J. 2016 Apr 15;23:191
pubmed: 27347280
Infect Genet Evol. 2015 Apr;31:142-8
pubmed: 25620375
J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i2-i18
pubmed: 32337595
Diagn Microbiol Infect Dis. 2012 Jul;73(3):290-1
pubmed: 22521054
Curr Pharm Des. 2019;25(12):1409-1423
pubmed: 31218955
J Antimicrob Chemother. 2020 Jun 1;75(6):1525-1529
pubmed: 32049276
Trop Med Infect Dis. 2019 Mar 26;4(1):
pubmed: 30917589
Bioorg Med Chem. 2021 Dec 27;55:116590
pubmed: 34973516
Pathogens. 2021 Jun 24;10(7):
pubmed: 34202800
J Infect. 2020 Dec;81(6):857-861
pubmed: 33115656
BMJ. 2016 Feb 08;352:h6420
pubmed: 26858245
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
pubmed: 17630334
Front Cell Infect Microbiol. 2016 Sep 21;6:98
pubmed: 27709102
J Infect Dev Ctries. 2011 Dec 13;5(12):850-5
pubmed: 22169783
Helicobacter. 2015 Dec;20(6):422-3
pubmed: 25735573
Clin Microbiol Rev. 2016 Jul;29(3):525-52
pubmed: 27076637
World J Microbiol Biotechnol. 2020 May 29;36(6):85
pubmed: 32468234
Nat Rev Microbiol. 2020 Apr;18(4):211-226
pubmed: 32071440
Nat Rev Dis Primers. 2018 May 31;4:18033
pubmed: 29849094
Lett Appl Microbiol. 2017 Jan;64(1):8-18
pubmed: 27783408
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
Germs. 2019 Sep 02;9(3):133-141
pubmed: 31646143
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Acta Microbiol Immunol Hung. 2017 Mar 1;64(1):71-80
pubmed: 28218003
J Med Microbiol. 2015 Jan;64(Pt 1):84-92
pubmed: 25432162
Antibiotics (Basel). 2022 Mar 21;11(3):
pubmed: 35326884
J Glob Antimicrob Resist. 2021 Sep;26:335-341
pubmed: 34303856
BMC Infect Dis. 2020 Dec 9;20(1):936
pubmed: 33297983
Antibiotics (Basel). 2020 Aug 01;9(8):
pubmed: 32752276
J Infect Public Health. 2020 Apr;13(4):637-643
pubmed: 31537511
Mol Biol Rep. 2020 Aug;47(8):6281-6294
pubmed: 32654052
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv24-7
pubmed: 24037141
BMC Infect Dis. 2021 Mar 6;21(1):244
pubmed: 33676421
J Glob Antimicrob Resist. 2017 Sep;10:321-325
pubmed: 28735058
Am J Infect Control. 2020 Apr;48(4):423-432
pubmed: 31676155
Lancet Infect Dis. 2013 Aug;13(8):672-9
pubmed: 23721756
East Mediterr Health J. 2012 Nov;18(11):1097-101
pubmed: 23301370
Antibiotics (Basel). 2021 Apr 26;10(5):
pubmed: 33925772
Microb Pathog. 2013 Aug-Sep;61-62:16-22
pubmed: 23643553
Infect Dis Obstet Gynecol. 2018 Nov 21;2018:7263849
pubmed: 30584266
Pan Afr Med J. 2020 Apr 06;35:97
pubmed: 32636995
J Infect Dev Ctries. 2017 Feb 28;11(2):136-142
pubmed: 28248674
PLoS One. 2021 Jun 30;16(6):e0251810
pubmed: 34191805
Molecules. 2021 May 02;26(9):
pubmed: 34063264
Ann Biol Clin (Paris). 2013 Jan-Feb;71(1):27-30
pubmed: 23396427
J Med Microbiol. 2011 Sep;60(Pt 9):1344-1352
pubmed: 21546559
J Appl Genet. 2020 May;61(2):265-273
pubmed: 31950434
Microbes Infect. 2012 Jul;14(7-8):573-83
pubmed: 22342898
Iran J Microbiol. 2017 Dec;9(6):318-323
pubmed: 29487729
Pathol Biol (Paris). 2012 Dec;60(6):e90-1
pubmed: 23123108
Int J Antimicrob Agents. 2016 Aug;48(2):119-26
pubmed: 27234675
Antibiotics (Basel). 2020 Jul 10;9(7):
pubmed: 32664222
Microb Drug Resist. 2017 Sep;23(6):727-732
pubmed: 27996373
Iran J Microbiol. 2014 Jun;6(3):175-83
pubmed: 25870751
Semin Diagn Pathol. 2019 May;36(3):182-186
pubmed: 31056277
Clin Infect Dis. 2017 Mar 15;64(suppl_1):S41-S47
pubmed: 28350903
Sex Transm Dis. 2017 May;44(5):261-265
pubmed: 28407640
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
Med Mal Infect. 2011 Apr;41(4):218-20
pubmed: 21195567
Med Mal Infect. 2011 Sep;41(9):469-74
pubmed: 21752563
Germs. 2021 Jun 02;11(2):189-198
pubmed: 34422691
Clin Microbiol Infect. 2014 Jul;20(7):605-23
pubmed: 24888414
BMC Res Notes. 2015 Aug 30;8:392
pubmed: 26319229
Curr Microbiol. 2021 Mar;78(3):867-878
pubmed: 33528603
Lancet Infect Dis. 2019 Nov;19(11):e392-e398
pubmed: 31427174
Adv Exp Med Biol. 2021;1323:35-69
pubmed: 32596751
Rev Sci Tech. 2017 Dec;36(3):935-946
pubmed: 30160689
Infect Genet Evol. 2016 Jun;40:200-204
pubmed: 26961592
Comp Immunol Microbiol Infect Dis. 1988;11(2):121-4
pubmed: 3053022
Can J Infect Dis Med Microbiol. 2017;2017:4082938
pubmed: 28408938
New Microbes New Infect. 2020 Sep 20;38:100764
pubmed: 33163199
Wounds. 2018 Apr;30(4):102-107
pubmed: 29521639
F1000Res. 2020 May 7;9:
pubmed: 32411353
Curr Drug Targets. 2015;16(3):272-80
pubmed: 25410409
Front Cell Infect Microbiol. 2021 Aug 18;11:720701
pubmed: 34490146
Ann Biol Clin (Paris). 2011 Jan-Feb;69(1):71-6
pubmed: 21463998
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31636071
Virulence. 2021 Dec;12(1):547-569
pubmed: 33522395
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
Int J Infect Dis. 2019 Aug;85:98-107
pubmed: 31176035
Lancet Infect Dis. 2017 Feb;17(2):153-163
pubmed: 27866944
Expert Rev Anti Infect Ther. 2022 Mar;20(3):463-472
pubmed: 34612762
J Infect Dev Ctries. 2019 Oct 31;13(10):892-898
pubmed: 32084019
J Infect Public Health. 2013 Dec;6(6):473-81
pubmed: 23999351
J Glob Antimicrob Resist. 2016 Dec;7:34-36
pubmed: 27568103
BMC Infect Dis. 2019 Jul 9;19(1):596
pubmed: 31288757
PLoS One. 2019 Jan 10;14(1):e0209425
pubmed: 30629614
Pathogens. 2021 Mar 24;10(4):
pubmed: 33804894
Int J Environ Res Public Health. 2020 Oct 19;17(20):
pubmed: 33086731
Am J Ther. 2017 May;24(3):e361-e369
pubmed: 28430673
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29203488
Prog Urol. 2014 Dec;24(16):1058-62
pubmed: 25310915
Ann Clin Microbiol Antimicrob. 2020 Jan 9;19(1):1
pubmed: 31918737